Medication Therapy Management: Guidances and Laws for Implementation and Expansion

If you cannot view the webcast, click here to download the free Flash Player.

Sponsored by Princeton CME

Target Audience

This activity is designed for managed care pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

Identify federal guidances to optimize the implementation and expansion of medication therapy management (MTM) programs
Outline the characteristics of Medicare beneficiaries who meet high-risk, eligibility criteria for inclusion in MTM programs
Contrast federally mandated pharmacist responsibilities and MTM-specific services for pharmacists and other providers
Institute quality improvement measures to assist patients and providers in optimizing MTM programs

Credit Eligibility

To be eligible for documentation of credit, participants must participate in the full educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: June 6, 2008

Expiration Date: June 6, 2009

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The audio/video presentation, post-test, and evaluation form are available as a click-through via the menu at the top of this page.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UPN 452-000-08-016-H03-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton CME may contact the Assistant Director of Continuing Education in writing. The Assistant Director of Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education may be made for a second level of review.

Grant Support

Supported by an educational grant from Solvay Pharmaceuticals, Inc.

Faculty

Presenter
Robert McMahan, PharmD, MBA, MATS
Director of Pharmacy
Fidelis Care
Rego Park, New York

Independent Clinical Reviewer
Fadia T. Shaya, PhD, MPH
Associate Professor, Associate Director
Center on Drugs and Public Policy
University of Maryland School of Pharmacy
Pharmaceutical Health Services Research
Baltimore, Maryland

Financial Disclosure and Conflicts of Interest
According to the disclosure policy of Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are viewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. McMahan: Scientific Consultant—Campbell Alliance, The GMR Group

Dr. Shaya has disclosed no relevant financial relationships with any commercial interests.

Planning committee Randy Robbin and John Savage, Princeton CME; Rosemary Hodgson and William Kormos, Princeton Media Communications have disclosed that they have no significant financial relationships.

Princeton CME requires faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved uses of drugs or devices will be discussed.